Reaction
Bloody Discharge reporting signals
As of the last recalculation, Bloody Discharge appears in 1,136 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is MEPERIDINE HYDROCHLORIDE (PRR 232.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Meperidine Hydrochloride | 106 | 232.4 | 235.1 |
| Misoprostol | 73 | 146.7 | 147.8 |
| Erythromycin | 101 | 108.2 | 108.8 |
| Diclofenac Potassium, Film Coated | 23 | 51.1 | 51.2 |
| Diclofenac Potassium Tablets | 23 | 51.1 | 51.2 |
| Metronidazole Topical | 103 | 43.5 | 43.5 |
| Diclofenac Potassium | 23 | 39.8 | 39.9 |
| Metronidazole | 114 | 36.2 | 36.3 |
| Levofloxacin | 100 | 33.2 | 33.3 |
| Levofloxacin In 5% Dextrose | 100 | 33.2 | 33.3 |
| Sulfasalazine | 111 | 28.7 | 28.7 |
| Hydroxychloroquine Sulfate | 113 | 25.1 | 25.2 |
| Diclofenac Sodium 1% | 46 | 24.5 | 24.6 |
| Diclofenac Sodium Topical | 46 | 24.5 | 24.6 |
| Diclofenac Sodium Topical Gel, 1% | 46 | 24.5 | 24.5 |
| Adalimumab-Adaz | 63 | 23.1 | 23.1 |
| Adalimumab-Fkjp | 55 | 22.8 | 22.8 |
| Cortisone Acetate | 15 | 22.5 | 22.6 |
| Adalimumab-Aaty | 55 | 22.3 | 22.3 |
| Leflunomide | 115 | 22.3 | 22.3 |
| Desoximetasone | 19 | 18.6 | 18.6 |
| Celecoxib | 118 | 18.2 | 18.2 |
| Bisoprolol Fumarate | 108 | 16.0 | 16.0 |
| Infliximab-Dyyb | 23 | 14.7 | 14.7 |
| Fluticasone Furoate | 9 | 13.7 | 13.7 |
| Miconazole Nitrate | 6 | 12.7 | 12.7 |
| Tobramycin Solution | 6 | 9.2 | 9.2 |
| Acalabrutinib | 6 | 9.1 | 9.1 |
| Tobramycin Sulfate | 6 | 8.9 | 8.9 |
| Sarilumab | 12 | 8.4 | 8.4 |
| Sevoflurane | 3 | 6.6 | 6.6 |
| Dornase Alfa | 7 | 6.6 | 6.6 |
| Orlistat | 6 | 4.3 | 4.3 |
| Copper | 5 | 2.1 | 2.1 |